View Clinical Trial (Medical Research Study)

Design and Evaluate 12 Week Group Therapy Intervention for HIV+ Methamphetamine Users and Deliver It Within an HIV/AIDS Primary Care Setting. - 1 - NCT00249678-90024A(Clinical Trial 132974)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Los Angeles
State:  
CA
Zip Code: 90024
Conditions: Behavior Therapy - Methamphetamine
Purpose: The purpose of this study is...to assess whether placing a substance abuse intervention for HIV+ methamphetamine users within an HIV medical care setting improves rates of follow-up on referral to treatment by primary care physicians; reduces drug use and sexual risk behaviors more than treatment-as-usual; and increases rates of adherence to HIV medication regimens.
Study summary:
Criteria: Inclusion Criteria: 1. HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the UCLA CARE clinic, aged 18-65 2. Willing to give informed consent and comply with study procedures; 3. Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications; 4. Diagnosed with current methamphetamine abuse as determined by MINI; and 5. Interested in seeking treatment for their methamphetamine abuse and in participating in this research project. Exclusion Criteria: 1. Unwilling to give, or withdrawal of, informed consent; 2. Inability to understand nature of study; 3. A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets DSM-IV-TR criteria for current bipolar disorder or a psychotic disorder); 4. Current suicidal ideation or suicide attempt within the past 3 months; and 5. Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI. 6. Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.
Study is available at: UCLA Medical Center
Los Angeles, CA 90024
United States
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 21, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.